Allosteric inhibition of the SARS-CoV-2 main protease - insights from mass spectrometry-based assays (2020)
Attributed to:
Applications of Mass Spectrometry to Membrane Protein Drug Development
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.07.29.226761
Publication URI: http://dx.doi.org/10.1101/2020.07.29.226761
Type: Preprint